Michael Ezrokhi

Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes

J. Michael Gaziano, Anthony H. Cincotta, Christopher M. O’Connor et al. · Diabetes Care · 2010 · 213 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either Cycloset™ or placebo

Richard E. Scranton, J. Michael Gaziano, Dean Rutty et al. · BMC Endocrine Disorders · 2007 · 55 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats

Michael Ezrokhi, Shuqin Luo, Yelena Trubitsyna et al. · Diabetology & Metabolic Syndrome · 2014 · 39 citations · Full text

Medicine, Pharmacology, Physiology +17

Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus

Bindu Chamarthi, J. Michael Gaziano, Lawrence Blonde et al. · Journal of Diabetes Research · 2015 · 35 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effect of Bromocriptine-Qr On Glycemic Control in Subjects with Uncontrolled Hyperglycemia On One or Two Oral Anti-Diabetes Agents

Aaron I. Vinik, Anthony H. Cincotta, Richard E. Scranton et al. · Endocrine Practice · 2012 · 33 citations

Medicine, Endocrinology, Pharmacology +16